Article Details

CAR-T Therapies Cost Prohibitive for Diffuse Large B-Cell Lymphoma Treatment

Retrieved on: 2022-12-21 01:46:41

Tags for this article:

Click the tags to see associated articles and topics

CAR-T Therapies Cost Prohibitive for Diffuse Large B-Cell Lymphoma Treatment. View article details on hiswai:

Excerpt

Antibody conjugates are monoclonal antibodies linked to cancer drug. CAR-T treatments are priced at about $400,000 and antibody conjugates in the ...

Article found on: www.managedhealthcareexecutive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up